Rick Chappell - Publications

Affiliations: 
University of Wisconsin, Madison, Madison, WI 
Area:
Statistics

38/163 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Lee AWM, Tung SY, Ng WT, Lee V, Ngan RKC, Choi HCW, Chan LLK, Siu LL, Ng AWY, Leung TW, Yiu HHY, O'Sullivan B, Chappell R. A multicenter, phase 3, randomized trial of concurrent chemoradiotherapy plus adjuvant chemotherapy versus radiotherapy alone in patients with regionally advanced nasopharyngeal carcinoma: 10-year outcomes for efficacy and toxicity. Cancer. PMID 28662313 DOI: 10.1002/Cncr.30850  0.331
2016 Chappell R, Zhu X. Describing Differences in Survival Curves. Jama Oncology. PMID 27123880 DOI: 10.1001/Jamaoncol.2016.0001  0.318
2016 Brower JV, Forman JD, Kupelian PA, Petereit DG, Gondi V, Lawton CA, Anger N, Saha S, Chappell R, Ritter MA. Quality of life outcomes from a dose-per-fraction escalation trial of hypofractionation in prostate cancer. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 26755165 DOI: 10.1016/J.Radonc.2015.12.018  0.32
2016 Lin Y, Chappell R, Gönen M. A systematic selection method for the development of cancer staging systems. Statistical Methods in Medical Research. 25: 1438-51. PMID 23698866 DOI: 10.1177/0962280213486853  0.309
2015 Lee AW, Ngan RK, Tung SY, Cheng A, Kwong DL, Lu TX, Chan AT, Chan LL, Yiu H, Ng WT, Wong F, Yuen KT, Yau S, Cheung FY, Chan OS, ... Chappell R, et al. Preliminary results of trial NPC-0501 evaluating the therapeutic gain by changing from concurrent-adjuvant to induction-concurrent chemoradiotherapy, changing from fluorouracil to capecitabine, and changing from conventional to accelerated radiotherapy fractionation in patients with locoregionally advanced nasopharyngeal carcinoma. Cancer. 121: 1328-38. PMID 25529384 DOI: 10.1002/Cncr.29208  0.303
2011 Lee AW, Tung SY, Chan AT, Chappell R, Fu YT, Lu TX, Tan T, Chua DT, O'Sullivan B, Tung R, Ng WT, Leung TW, Leung SF, Yau S, Zhao C, et al. A randomized trial on addition of concurrent-adjuvant chemotherapy and/or accelerated fractionation for locally-advanced nasopharyngeal carcinoma. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 98: 15-22. PMID 20971520 DOI: 10.1016/J.Radonc.2010.09.023  0.303
2010 Lawrence JA, Forrest LJ, Turek MM, Miller PE, Mackie TR, Jaradat HA, Vail DM, Dubielzig RR, Chappell R, Mehta MP. Proof of principle of ocular sparing in dogs with sinonasal tumors treated with intensity-modulated radiation therapy. Veterinary Radiology & Ultrasound : the Official Journal of the American College of Veterinary Radiology and the International Veterinary Radiology Association. 51: 561-70. PMID 20973393 DOI: 10.1111/J.1740-8261.2010.01695.X  0.307
2010 Lee AW, Tung SY, Chua DT, Ngan RK, Chappell R, Tung R, Siu L, Ng WT, Sze WK, Au GK, Law SC, O'Sullivan B, Yau TK, Leung TW, Au JS, et al. Randomized trial of radiotherapy plus concurrent-adjuvant chemotherapy vs radiotherapy alone for regionally advanced nasopharyngeal carcinoma. Journal of the National Cancer Institute. 102: 1188-98. PMID 20634482 DOI: 10.1093/Jnci/Djq258  0.35
2009 Steinberg DM, Fine J, Chappell R. Sample size for positive and negative predictive value in diagnostic research using case-control designs. Biostatistics (Oxford, England). 10: 94-105. PMID 18556677 DOI: 10.1093/Biostatistics/Kxn018  0.489
2008 Bailey HH, Attia S, Love RR, Fass T, Chappell R, Tutsch K, Harris L, Jumonville A, Hansen R, Shapiro GR, Stewart JA. Phase II trial of daily oral perillyl alcohol (NSC 641066) in treatment-refractory metastatic breast cancer. Cancer Chemotherapy and Pharmacology. 62: 149-57. PMID 17885756 DOI: 10.1007/S00280-007-0585-6  0.315
2008 Huang B, Chappell R. Three-dose-cohort designs in cancer phase I trials. Statistics in Medicine. 27: 2070-93. PMID 17764082 DOI: 10.1002/Sim.3054  0.321
2007 Yuan Z, Chappell R, Bailey H. The continual reassessment method for multiple toxicity grades: a Bayesian quasi-likelihood approach. Biometrics. 63: 173-9. PMID 17447942 DOI: 10.1111/J.1541-0420.2006.00666.X  0.321
2006 Lee AW, Tung SY, Chan AT, Chappell R, Fu YT, Lu TX, Tan T, Chua DT, O'sullivan B, Xu SL, Pang ES, Sze WM, Leung TW, Kwan WH, Chan PT, et al. Preliminary results of a randomized study (NPC-9902 Trial) on therapeutic gain by concurrent chemotherapy and/or accelerated fractionation for locally advanced nasopharyngeal carcinoma. International Journal of Radiation Oncology, Biology, Physics. 66: 142-51. PMID 16904519 DOI: 10.1016/J.Ijrobp.2006.03.054  0.319
2005 Lee AW, Lau WH, Tung SY, Chua DT, Chappell R, Xu L, Siu L, Sze WM, Leung TW, Sham JS, Ngan RK, Law SC, Yau TK, Au JS, O'Sullivan B, et al. Preliminary results of a randomized study on therapeutic gain by concurrent chemotherapy for regionally-advanced nasopharyngeal carcinoma: NPC-9901 Trial by the Hong Kong Nasopharyngeal Cancer Study Group. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 6966-75. PMID 16192584 DOI: 10.1200/Jco.2004.00.7542  0.33
2005 Jiang H, Fine JP, Chappell R. Semiparametric analysis of survival data with left truncation and dependent right censoring. Biometrics. 61: 567-75. PMID 16011706 DOI: 10.1111/J.1541-0420.2005.00335.X  0.527
2005 JIANG H, FINE JP, KOSOROK MR, CHAPPELL R. Pseudo Self-Consistent Estimation of a Copula Model with Informative Censoring Scandinavian Journal of Statistics. 32: 1-20. DOI: 10.1111/J.1467-9469.2005.00412.X  0.519
2004 Lee AW, Lau WH, Tung SY, Chua D, Chappell R, Siu L, Lau J, Law SC, Xu L. Prospective randomized study on therapeutic gain achieved by addition of chemotherapy for T1-4N2-3M0 Nasopharyngeal Carcinoma (NPC). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 22: 5506. PMID 28014202 DOI: 10.1200/Jco.2004.22.14_Suppl.5506  0.308
2004 Meier P, Karrison T, Chappell R, Xie H. The Price of Kaplan–Meier Journal of the American Statistical Association. 99: 890-896. DOI: 10.1198/016214504000001259  0.318
2003 Karrison TG, Huo D, Chappell R. A group sequential, response-adaptive design for randomized clinical trials Controlled Clinical Trials. 24: 506-522. PMID 14500050 DOI: 10.1016/S0197-2456(03)00092-8  0.306
2003 Jiang H, Chappell R, Fine JP. Estimating the distribution of nonterminal event time in the presence of mortality or informative dropout. Controlled Clinical Trials. 24: 135-46. PMID 12689735 DOI: 10.1016/S0197-2456(02)00307-0  0.531
2002 Pan W, Chappell R. Estimation in the cox proportional hazards model with left-truncated and interval-censored data. Biometrics. 58: 64-70. PMID 11890328 DOI: 10.1111/J.0006-341X.2002.00064.X  0.339
2002 Kosorok MR, Fine JP, Jiang H, Chappell R. Asymptotic theory for the gamma frailty model with dependent censoring Annals of the Institute of Statistical Mathematics. 54: 476-499. DOI: 10.1023/A:1022450708498  0.52
2001 Sanghavi SN, Miranpuri SS, Chappell R, Buatti JM, Sneed PK, Suh JH, Regine WF, Weltman E, King VJ, Goetsch SJ, Breneman JC, Sperduto PW, Scott C, Mabanta S, Mehta MP. Radiosurgery for patients with brain metastases: A multi-institutional analysis, stratified by the RTOG recursive partitioning analysis method International Journal of Radiation Oncology Biology Physics. 51: 426-434. PMID 11567817 DOI: 10.1016/S0360-3016(01)01622-4  0.306
2001 Cheung YK, Chappell R. Sequential designs for phase I clinical trials with late-onset toxicities. Biometrics. 56: 1177-82. PMID 11129476 DOI: 10.1111/J.0006-341X.2000.01177.X  0.323
2001 Fine JP, Jiang H, Chappell R. On semi-competing risks data Biometrika. 88: 907-919. DOI: 10.1093/Biomet/88.4.907  0.526
2000 Lee AW, Foo W, Law SC, Peters LJ, Poon YF, Chappell R, Sze WM, Tung SY, Lau WH, Ho JH. Total biological effect on late reactive tissues following reirradiation for recurrent nasopharyngeal carcinoma. International Journal of Radiation Oncology, Biology, Physics. 46: 865-72. PMID 10705007 DOI: 10.1016/S0360-3016(99)00512-X  0.341
1999 Lee AW, Foo W, Law SC, Poon YF, O SK, Tung SY, Sze WM, Chappell R, Lau WH, Ho JH. Staging of nasopharyngeal carcinoma: from Ho's to the new UICC system. International Journal of Cancer. Journal International Du Cancer. 84: 179-87. PMID 10096252 DOI: 10.1002/(Sici)1097-0215(19990420)84:2<179::Aid-Ijc15>3.0.Co;2-6  0.306
1998 Lee AW, Foo W, Chappell R, Fowler JF, Sze WM, Poon YF, Law SC, Ng SH, O SK, Tung SY, Lau WH, Ho JH. Effect of time, dose, and fractionation on temporal lobe necrosis following radiotherapy for nasopharyngeal carcinoma. International Journal of Radiation Oncology, Biology, Physics. 40: 35-42. PMID 9422555 DOI: 10.1016/S0360-3016(97)00580-4  0.333
1998 Pan W, Chappell R. Estimating survival curves with left-truncated and interval-censored data under monotone hazards. Biometrics. 54: 1053-1060. DOI: 10.2307/2533856  0.301
1997 Leborgne F, Fowler JF, Leborgne JH, Zubizarreta E, Chappell R. Biologically effective doses in medium dose rate brachytherapy of cancer of the cervix. Radiation Oncology Investigations. 5: 289-299. PMID 9436246 DOI: 10.1002/(Sici)1520-6823(1997)5:6<289::Aid-Roi5>3.0.Co;2-U  0.314
1996 Leborgne F, Fowler JF, Leborgne J, Zubizarreta E, Chappell R. Fractionation in medium dose rate brachytherapy of cancer of the cervix. International Journal of Radiation Oncology Biology Physics. 35: 907-914. PMID 8751399 DOI: 10.1016/0360-3016(96)00184-8  0.306
1995 Lee AW, Chan DK, Fowler JF, Poon YF, Foo W, Law SC, O SK, Tung SY, Chappell R. Effect of time, dose and fractionation on local control of nasopharyngeal carcinoma. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 36: 24-31. PMID 8525022 DOI: 10.1016/0167-8140(95)01579-6  0.325
1995 Petereit DG, Sarkaria JN, Chappell R, Fowler JF, Hartmann TJ, Kinsella TJ, Stitt JA, Thomadsen BR, Buchler DA. The adverse effect of treatment prolongation in cervical carcinoma International Journal of Radiation Oncology, Biology, Physics. 32: 1301-1307. PMID 7635769 DOI: 10.1016/0360-3016(94)00635-X  0.313
1995 Wang Y, Wahba G, Chappell R, Gu C. Simulation studies of smoothing parameter estimates and bayesian confidence intervals in bernoulli ss anova models Communications in Statistics - Simulation and Computation. 24: 1037-1059. DOI: 10.1080/03610919508813292  0.569
1995 Chappell R, Nondahl DM, Fowler JF. Modeling Dose and Local Control in Radiotherapy Journal of the American Statistical Association. 90: 829-838. DOI: 10.1080/01621459.1995.10476581  0.312
1994 Sarkaria JN, Petereit DG, Stitt JA, Hartman T, Chappell R, Thomadsen BR, Buchler DA, Fowler JF, Kinsella TJ. A comparison of the efficacy and complication rates of low dose-rate versus high dose-rate brachytherapy in the treatment of uterine cervical carcinoma International Journal of Radiation Oncology, Biology, Physics. 30: 75-82. PMID 8083131 DOI: 10.1016/0360-3016(94)90521-5  0.321
1994 Mehta MP, Masciopinto J, Rozental J, Levin A, Chappell R, Bastin K, Miles J, Turski P, Kubsad S, Mackie T, Kinsella T. Stereotactic radiosurgery for glioblastoma multiforme: Report of a prospective study evaluating prognostic factors and analyzing long-term survival advantage International Journal of Radiation Oncology Biology Physics. 30: 541-549. PMID 7928484 DOI: 10.1016/0360-3016(92)90939-F  0.327
1988 Michelassi F, Block GE, Vannucci L, Montag A, Chappell R. A 5− to 21-Year Follow-up and Analysis of 250 Patients with Rectal Adenocarcinoma Annals of Surgery. 208: 379-389. PMID 3421761 DOI: 10.1097/00000658-198809000-00016  0.32
Low-probability matches (unlikely to be authored by this person)
2001 Fowler J, Chappell R, Ritter M. Is α/β for prostate tumors really low? International Journal of Radiation Oncology Biology Physics. 50: 1021-1031. PMID 11429230 DOI: 10.1016/S0360-3016(01)01607-8  0.299
2002 Cheung YK, Chappell R. A simple technique to evaluate model sensitivity in the continual reassessment method Biometrics. 58: 671-674. PMID 12230003 DOI: 10.1111/J.0006-341X.2002.00671.X  0.298
2018 Ng WT, Tung SY, Lee V, Ngan RKC, Choi HCW, Chan LLK, Leung TW, Siu LL, Lu TX, Tan T, Tan EH, Sze HCK, Ng AWY, Yiu HHY, O'Sullivan B, ... Chappell R, et al. Concurrent-Adjuvant Chemoradiation Therapy for Stage III-IVB Nasopharyngeal Carcinoma-Exploration for Achieving Optimal 10-Year Therapeutic Ratio. International Journal of Radiation Oncology, Biology, Physics. PMID 29885997 DOI: 10.1016/J.Ijrobp.2018.04.069  0.298
1998 Pan W, Chappell R, Kosorok MR. On consistency of the monotone MLE of survival for left truncated and interval-censored data Statistics & Probability Letters. 38: 49-57. DOI: 10.1016/S0167-7152(97)00153-3  0.298
2012 Tevaarwerk A, Wilding G, Eickhoff J, Chappell R, Sidor C, Arnott J, Bailey H, Schelman W, Liu G. Phase I study of continuous MKC-1 in patients with advanced or metastatic solid malignancies using the modified Time-to-Event Continual Reassessment Method (TITE-CRM) dose escalation design. Investigational New Drugs. 30: 1039-45. PMID 21225315 DOI: 10.1007/S10637-010-9629-6  0.297
2011 Bowen S, Chappell R, Bentzen S, Deveau M, Forrest L, Jeraj R. TU-A-BRC-04: Quantifying the Predictive Power of Multiparametric PET Imaging in a Prospective Veterinary Dose Escalation Trial through Voxel Regression Medical Physics. 38: 3742-3742. DOI: 10.1118/1.3613080  0.297
2011 Lee AW, Tung SY, Ngan RK, Chappell R, Chua DT, Lu TX, Siu L, Tan T, Chan LK, Ng WT, Leung TW, Fu YT, Au GK, Zhao C, O'Sullivan B, et al. Factors contributing to the efficacy of concurrent-adjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma: combined analyses of NPC-9901 and NPC-9902 Trials. European Journal of Cancer (Oxford, England : 1990). 47: 656-66. PMID 21112774 DOI: 10.1016/J.Ejca.2010.10.026  0.297
2019 McDaniel LS, Yu M, Chappell R. Analysis and Design of Clinical Trials Using Additive Hazards Survival Endpoints Statistics in Biopharmaceutical Research. 11: 274-282. DOI: 10.1080/19466315.2019.1575278  0.296
2010 Lepeak LM, Wilding G, Eickhoff JC, Chappell R, Sidor C, Arnott J, Jeraj R, Perlman S, Liu G, Tevaarwerk A. Phase I study of continuous MKC-1 (cMKC-1) in patients (pts) with advanced or metastatic solid malignancies using a modified time-to-event continual reassessment method (TITE-CRM) for dose assignment. Journal of Clinical Oncology. 28: e13001-e13001. DOI: 10.1200/Jco.2010.28.15_Suppl.E13001  0.296
1996 Newton MA, Czado C, Chappell R. Bayesian Inference for Semiparametric Binary Regression Journal of the American Statistical Association. 91: 142-153. DOI: 10.1080/01621459.1996.10476671  0.295
2020 Lee AWM, Ngan RKC, Ng WT, Tung SY, Cheng AAC, Kwong DLW, Lu TX, Chan ATC, Sze HCK, Yiu HHY, Wong FCS, Yuen KT, Chappell R, Choi HCW. NPC-0501 trial on the value of changing chemoradiotherapy sequence, replacing 5-fluorouracil with capecitabine, and altering fractionation for patients with advanced nasopharyngeal carcinoma. Cancer. PMID 32497261 DOI: 10.1002/Cncr.32972  0.292
1996 Takanishi DM, Hart J, Covarelli P, Chappell R, Michelassi F. Ploidy as a Prognostic Feature in Colonic Adenocarcinoma Archives of Surgery. 131: 587-592. PMID 8645063 DOI: 10.1001/Archsurg.1996.01430180013002  0.291
1999 Lee AW, Foo W, Law SC, Poon YF, Sze WM, O SK, Tung SY, Chappell R, Lau WH, Ho JH. Recurrent nasopharyngeal carcinoma: the puzzles of long latency. International Journal of Radiation Oncology, Biology, Physics. 44: 149-56. PMID 10219808 DOI: 10.1016/S0360-3016(98)00524-0  0.29
1994 Fowler JF, Chappell R. Effect of overall time and dose on the response of glottic carcinoma of the larynx to radiotherapy European Journal of Cancer. 30: 719-721. DOI: 10.1016/0959-8049(94)90558-4  0.29
1991 Michelassi F, Ayala JJ, Balestracci T, Goldberg R, Chappell R, Block GE. Verification of a new clinicopathologic staging system for colorectal adenocarcinoma. Annals of Surgery. 214: 11-18. PMID 2064465 DOI: 10.1097/00000658-199107000-00003  0.289
2015 Li C, Dowling NM, Chappell R. Quantile regression with a change-point model for longitudinal data: An application to the study of cognitive changes in preclinical alzheimer's disease. Biometrics. PMID 25892034 DOI: 10.1111/Biom.12313  0.287
1997 Clark BG, Souhami L, Roman TN, Chappell R, Evans MD, Fowler JF. The prediction of late rectal complications in patients treated with high dose-rate brachytherapy for carcinoma of the cervix. International Journal of Radiation Oncology, Biology, Physics. 38: 989-93. PMID 9276363 DOI: 10.1016/S0360-3016(97)00074-6  0.286
2002 Patel R, Tomé W, Orton N, Olivera G, Chinnaiyan P, Chappell R, Mackie T, Ritter M. The use of an endorectal balloon catheter and ultrasound localization in conformal radiation therapy for prostate cancer: a DVH analysis of rectal dose-sparing with 3D-CRT, IMRT, and helical tomotherapy International Journal of Radiation Oncology*Biology*Physics. 54: 259. DOI: 10.1016/S0360-3016(02)03507-1  0.285
2015 McDaniel LS, Yu M, Chappell R. Sample size under the additive hazards model. Clinical Trials (London, England). PMID 26572562 DOI: 10.1177/1740774515614542  0.284
1996 Auchter RM, Lamond JP, Alexander E, Buatti JM, Chappell R, Friedman WA, Kinsella TJ, Levin AB, Noyes WR, Schultz CJ, Loeffler JS, Mehta MP. A multiinstitutional outcome and prognostic factor analysis of radiosurgery for resectable single brain metastasis. International Journal of Radiation Oncology, Biology, Physics. 35: 27-35. PMID 8641923 DOI: 10.1016/S0360-3016(96)85008-5  0.284
1991 Michelassi F, Balestracci T, Chappell R, Block GE. Primary and Recurrent Crohn's Disease. Experience With 1379 Patients Annals of Surgery. 214: 230-240. PMID 1929605 DOI: 10.1097/00000658-199109000-00006  0.284
2020 Chandereng T, Wei X, Chappell R. Imbalanced randomization in clinical trials. Statistics in Medicine. PMID 32246484 DOI: 10.1002/Sim.8539  0.283
1999 Pan W, Chappell R. A Note on Inconsistency of NPMLE of the Distribution Function from Left Truncated and Case I Interval Censored Data Lifetime Data Analysis. 5: 281-291. PMID 10518374 DOI: 10.1023/A:1009632400580  0.283
2004 Schulz CA, Mehta MP, Badie B, McGinn CJ, Robins HI, Hayes L, Chappell R, Volkman J, Binger K, Arzoomanian R, Simon K, Alberti D, Feierabend C, Tutsch KD, Kunugi KA, et al. Continuous 28-day iododeoxyuridine infusion and hyperfractionated accelerated radiotherapy for malignant glioma: a phase I clinical study. International Journal of Radiation Oncology, Biology, Physics. 59: 1107-15. PMID 15234045 DOI: 10.1016/J.Ijrobp.2003.12.007  0.282
1998 Pan W, Chappell R. Computation of the NPMLE of distribution functions for interval censored and truncated data with applications to the Cox model Computational Statistics & Data Analysis. 28: 33-50. DOI: 10.1016/S0167-9473(98)00026-7  0.277
2010 Nondahl DM, Cruickshanks KJ, Wiley TL, Klein BE, Klein R, Chappell R, Tweed TS. The ten-year incidence of tinnitus among older adults. International Journal of Audiology. 49: 580-5. PMID 20560859 DOI: 10.3109/14992021003753508  0.276
2011 Li C, Wei Y, Chappell R, He X. Bent line quantile regression with application to an allometric study of land mammals' speed and mass. Biometrics. 67: 242-9. PMID 20528859 DOI: 10.1111/J.1541-0420.2010.01436.X  0.276
2001 Lee AW, Sze WM, Yau TK, Yeung RM, Chappell R, Fowler JF. Retrospective analysis on treating nasopharyngeal carcinoma with accelerated fractionation (6 fractions per week) in comparison with conventional fractionation (5 fractions per week): report on 3-year tumor control and normal tissue toxicity. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 58: 121-30. PMID 11166862 DOI: 10.1016/S0167-8140(00)00312-1  0.276
1995 Grant MD, Piotrowski ZH, Chappell R. Self-reported health and survival in the longitudinal study of aging, 1984–1986 Journal of Clinical Epidemiology. 48: 375-387. PMID 7897459 DOI: 10.1016/0895-4356(94)00143-E  0.274
1998 Kalishman JB, Chappell R, Flood LA, Dubielzig RR. A matched observational study of survival in cats with enucleation due to diffuse iris melanoma. Veterinary Ophthalmology. 1: 25-29. PMID 11397206 DOI: 10.1046/J.1463-5224.1998.00006.X  0.273
2004 Lee AW, Lau W, Tung SY, Chua D, Ngan R, Chappell R, Siu L, Xu S, Lau J, Sze W, Leung T, Sham J. Prospective randomized study on therapeutic gain by concurrent chemoradiation for nasopharyngeal carcinoma with advanced nodal disease International Journal of Radiation Oncology Biology Physics. 60. DOI: 10.1016/J.Ijrobp.2004.06.080  0.273
1990 Chappell R. Sampling design of multiwave studies with an application to the Massachusetts health care panel study Controlled Clinical Trials. 11: 257-258. DOI: 10.1002/Sim.4780101209  0.272
2009 Al-Niaimi A, Manuelli B, Safdar N, Chappell R, Seo S, Kushner D, Connor J, Hartenbach E. Survival with surgical versus medical treatment of patients with bowel obstruction secondary to ovarian cancer recurrence: A 15-year experience. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: e16515. PMID 27960754 DOI: 10.1200/Jco.2009.27.15_Suppl.E16515  0.272
1996 Steinherz PG, Gaynon PS, Breneman JC, Cherlow JM, Grossman NJ, Kersey JH, Johnstone HS, Sather HN, Trigg ME, Chappell R, Hammond D, Bleyer WA. Cytoreduction and prognosis in acute lymphoblastic leukemia--the importance of early marrow response: report from the Childrens Cancer Group. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 14: 389-98. PMID 8636748 DOI: 10.1200/Jco.1996.14.2.389  0.272
2016 Brower JV, Zhang S, Ritter MA, Bassetti M, Chappell R, Baschnagel AM. Overall Survival Benefit of Intensity Modulated Compared With 3D-Conformal Radiation Therapy in the Definitive Management of Esophageal Cancer: Analysis of the National Cancer Data Base (NCDB). International Journal of Radiation Oncology, Biology, Physics. 96: S187. PMID 27675740 DOI: 10.1016/J.Ijrobp.2016.06.467  0.271
1994 Steeves RA, Stitt JA, Chappell R, Wolberg WH, Kinsella TJ. Simple numerical system for scoring the cosmetic effects of radiation and surgery post-conservation therapy for breast cancer Radiation Oncology Investigations. 2: 194-198. DOI: 10.1002/Roi.2970020407  0.271
1988 Michelassi F, Vannucci LE, Montag A, Chappell R, Rodgers J, Block GE. Ras oncogene expression as a prognostic indicator in rectal adenocarcinoma Journal of Surgical Research. 45: 15-20. PMID 3392989 DOI: 10.1016/0022-4804(88)90015-7  0.27
1992 Chappell R. A note on linear rank tests and Gill and Schumacher's tests of proportionality Biometrika. 79: 199-201. DOI: 10.1093/Biomet/79.1.199  0.27
1989 Chappell R. Fitting bent lines to data, with applications to allometry. Journal of Theoretical Biology. 138: 235-256. PMID 2607772 DOI: 10.1016/S0022-5193(89)80141-9  0.27
1995 Lee AWM, Chan DKK, Fowler JF, Poon YF, Foo W, Law SCK, Tung SY, Chappell R. Effect of time, dose and fractionation on local control of nasopharyngeal carcinoma Medical Dosimetry. 20: 313. DOI: 10.1016/0958-3947(95)01597-3  0.269
2013 Fontaine ML, McDaniel L, Kubicek L, Chappell R, Forrest L, Jeraj R. WE-C-103-11: Impact of Patient Parameters On the Repeatability of DCE-CT Kinetic Analysis Medical Physics. 40: 483-483. DOI: 10.1118/1.4815560  0.269
2006 Welsh JS, Lock M, Harari PM, Tomé WA, Fowler J, Mackie TR, Ritter M, Kapatoes J, Forrest L, Chappell R, Paliwal B, Mehta MP. Clinical implementation of adaptive helical tomotherapy: a unique approach to image-guided intensity modulated radiotherapy. Technology in Cancer Research & Treatment. 5: 465-79. PMID 16981789 DOI: 10.1177/153303460600500503  0.267
1991 Chappell R. A flaw in the generalized maximum likelihood estimate with a suggested repair Controlled Clinical Trials. 12: 703. DOI: 10.1016/0197-2456(91)90295-W  0.267
2003 Chinnaiyan P, Tomée W, Patel R, Chappell R, Ritter M. 3D-ultrasound guided radiation therapy in the post-prostatectomy setting. Technology in Cancer Research & Treatment. 2: 455-8. PMID 14529311 DOI: 10.1177/153303460300200511  0.267
2003 Patel RR, Orton N, Tomé WA, Chappell R, Ritter MA. Rectal dose sparing with a balloon catheter and ultrasound localization in conformal radiation therapy for prostate cancer. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 67: 285-94. PMID 12865176 DOI: 10.1016/S0167-8140(03)00056-2  0.266
2005 Petereit DG, Rogers D, Burhansstipanov L, Kaur J, Govern F, Howard SP, Osburn CH, Coleman CN, Fowler JF, Chappell R, Mehta MP. Walking forward: the South Dakota Native American project. Journal of Cancer Education : the Official Journal of the American Association For Cancer Education. 20: 65-70. PMID 15916524 DOI: 10.1207/S15430154Jce2001S_14  0.265
2015 Hotujec BT, Spencer RJ, Donnelly MJ, Bruggink SM, Rose SL, Al-Niaimi A, Chappell R, Stewart SL, Kushner DM. Transversus abdominis plane block in robotic gynecologic oncology: a randomized, placebo-controlled trial. Gynecologic Oncology. 136: 460-5. PMID 25462201 DOI: 10.1016/J.Ygyno.2014.11.013  0.264
2002 Sneed PK, Suh JH, Goetsch SJ, Sanghavi SN, Chappell R, Buatti JM, Regine WF, Weltman E, King VJ, Breneman JC, Sperduto PW, Mehta MP. A multi-institutional review of radiosurgery alone vs. radiosurgery with whole brain radiotherapy as the initial management of brain metastases International Journal of Radiation Oncology Biology Physics. 53: 519-526. PMID 12062592 DOI: 10.1016/S0360-3016(02)02770-0  0.263
1989 Feinstein SB, Keller MW, Kerber RE, Vandenberg B, Hoyte J, Kutruff C, Bingle J, Fraker TD, Chappell R, Welsh AH. Sonicated echocardiographic contrast agents: reproducibility studies Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography. 2: 125-131. PMID 2629861 DOI: 10.1016/S0894-7317(89)80075-6  0.262
2011 Einstein M, Hollenberg J, Hartenbach E, Chappell R, Kushner D, Evans A, Connor J. Stage IB2 cervical cancer: A decision analysis comparing quality-adjusted survival associated with chemoradiation versus radical surgery with tailored adjuvant chemoradiation Gynecologic Oncology. 120. DOI: 10.1016/J.Ygyno.2010.12.071  0.262
1993 Chappell R, Branch LG. The Goldilocks dilemma in survey design and its solution. Journal of Clinical Epidemiology. 46: 309-12. PMID 8455056 DOI: 10.1016/0895-4356(93)90079-G  0.261
1994 Chappell R, Fowler JF. Steepness of dose-response curve for larynx cancer Radiotherapy and Oncology. 30: 90. PMID 8153386 DOI: 10.1016/0167-8140(94)90014-0  0.261
2005 Kushner DM, LaGalbo R, Connor JP, Chappell R, Stewart SL, Hartenbach EM. Use of a bupivacaine continuous wound infusion system in gynecologic oncology: a randomized trial. Obstetrics and Gynecology. 106: 227-33. PMID 16055569 DOI: 10.1097/01.Aog.0000171111.68015.Af  0.259
2013 Lin Y, Yu M, Wang S, Chappell R, Imperiale TF. Advanced colorectal neoplasia risk stratification by penalized logistic regression. Statistical Methods in Medical Research. PMID 23907780 DOI: 10.1177/0962280213497432  0.258
2017 Chappell R, Durkalski V, Joffe S. University of Pennsylvania ninth annual conference on statistical issues in clinical trials: Where are we with adaptive clinical trial designs? (morning panel discussion). Clinical Trials (London, England). 14: 441-450. PMID 28825324 DOI: 10.1177/1740774517723590  0.254
1999 Sanghavi SN, Miranpuri SS, Chappell R, Mabanta S, Suh JH, Regine WF, Weltman E, Sneed PK, Goetsch SJ, Breneman JC, Sperduto PW, Scott C, Buatti JM, Mehta MP. 48 Multi-institutional survival analysis of brain metastases patients treated with radiosurgery, stratified by RTOG RPA classification International Journal of Radiation Oncology Biology Physics. 45: 171. DOI: 10.1016/S0360-3016(99)90066-4  0.254
2004 Patel R, Tome W, Chappell R, Ritter M. Use of a balloon catheter during conformal prostate irradiation allows high dose rectal-sparing and results in reduced late rectal bleeding International Journal of Radiation Oncology*Biology*Physics. 60: S457. DOI: 10.1016/J.Ijrobp.2004.07.366  0.253
2004 Sze WM, Lee AW, Yau TK, Yeung RM, Lau KY, Leung SK, Hung AW, Lee MC, Chappell R, Chan K. Primary tumor volume of nasopharyngeal carcinoma: prognostic significance for local control. International Journal of Radiation Oncology, Biology, Physics. 59: 21-7. PMID 15093895 DOI: 10.1016/J.Ijrobp.2003.10.027  0.252
2007 Chappell R, Karrison T. Continuous Bayesian adaptive randomization based on event times with covariates by Cheung et al., Statistics in Medicine 2006; 25:55-70. Statistics in Medicine. 26: 3050-2; author reply. PMID 17163577 DOI: 10.1002/Sim.2765  0.252
2001 Mehta M, Scrimger R, Mackie R, Paliwal B, Chappell R, Fowler J. A new approach to dose escalation in non-small-cell lung cancer. International Journal of Radiation Oncology, Biology, Physics. 49: 23-33. PMID 11163494 DOI: 10.1016/S0360-3016(00)01374-2  0.251
2014 Chuang-Stein C, Follman D, Chappell R. University of Pennsylvania 6th annual conference on statistical issues in clinical trials: Dynamic treatment regimes (afternoon session). Clinical Trials (London, England). 11: 457-466. PMID 25053777 DOI: 10.1177/1740774514538552  0.247
2002 Lee AW, Kwong DL, Leung SF, Tung SY, Sze WM, Sham JS, Teo PM, Leung TW, Wu PM, Chappell R, Peters LJ, Fowler JF. Factors affecting risk of symptomatic temporal lobe necrosis: significance of fractional dose and treatment time. International Journal of Radiation Oncology, Biology, Physics. 53: 75-85. PMID 12007944 DOI: 10.1016/S0360-3016(02)02711-6  0.245
2003 Lee AW, Foo W, Mang O, Sze WM, Chappell R, Lau WH, Ko WM. Changing epidemiology of nasopharyngeal carcinoma in Hong Kong over a 20-year period (1980-99): an encouraging reduction in both incidence and mortality. International Journal of Cancer. 103: 680-5. PMID 12494479 DOI: 10.1002/Ijc.10894  0.245
2000 Chappell R. Student scholarship competition manuscripts: relevance, rigor, and promise. Controlled Clinical Trials. 21: 138-9. PMID 10715511 DOI: 10.1016/S0197-2456(00)00044-1  0.243
2015 Wichmann MA, Cruickshanks KJ, Carlsson CM, Chappell R, Fischer ME, Klein BE, Klein R, Schubert CR. NSAID Use and Incident Cognitive Impairment in a Population-based Cohort. Alzheimer Disease and Associated Disorders. PMID 26079710 DOI: 10.1097/Wad.0000000000000098  0.242
1997 Littman P, Chappell R, Seiferheld W, Bolles C, Huber R, Sanders B. 2105 Modification of risk of recurrence for radical prostatectomy patients with positive surgical margins International Journal of Radiation Oncology*Biology*Physics. 39: 293. DOI: 10.1016/S0360-3016(97)80873-5  0.242
2003 Chappell R. Multivariate Statistical Modelling Based on Generalized Linear Models (2nd ed.). Ludwig FAHRMEIR and Gerhard TUTZ Journal of the American Statistical Association. 98: 776-777. DOI: 10.1198/Jasa.2003.S302  0.241
2016 Morris ZS, Saha S, Magnuson WJ, Morris BA, Borkenhagen JF, Ching A, Hirose G, McMurry V, Francis DM, Harari PM, Chappell R, Tsuji S, Ritter MA. Increased tumor response to neoadjuvant therapy among rectal cancer patients taking angiotensin-converting enzyme inhibitors or angiotensin receptor blockers. Cancer. PMID 27203227 DOI: 10.1002/Cncr.30079  0.238
2004 Petereit DG, Rogers D, Govern F, Coleman N, Osburn CH, Howard SP, Kaur J, Burhansstipanov L, Fowler CJ, Chappell R, Mehta MP. Increasing access to clinical cancer trials and emerging technologies for minority populations: the Native American Project. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 22: 4452-5. PMID 15542797 DOI: 10.1200/Jco.2004.01.119  0.235
2017 Turski CA, Kessler-Jones A, Hermann B, Hsu D, Jones J, Seeger S, Chappell R, Ikonomidou C. Feasibility and Dose Tolerability of High Definition Transcranial Direct Current Stimulation in healthy adults Brain Stimulation. 10. DOI: 10.1016/J.Brs.2017.04.013  0.234
2008 Yu Q, Chappell R, Wong GYC, Hsu Y, Mazur M. Relationship Between the Cox, Lehmann, Weibull, and Accelerated Lifetime Models Communications in Statistics-Theory and Methods. 37: 1458-1470. DOI: 10.1080/03610920701666336  0.234
2006 Lalich M, Wilding G, Kolesar J, McNeel DG, Schell K, Leith C, Chappell R, Marnocha R, Alberti D, Liu G. A phase I study of antisense Bcl-2 oligonucleotide (G3139) in combination with carboplatin (C) and paclitaxel (T) in patients with advanced solid tumors. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 24: 13006. PMID 27955410 DOI: 10.1200/Jco.2006.24.18_Suppl.13006  0.234
2014 Ithapu VK, Singh V, Okonkwo O, Chappell R, Johnson SC. A Predictive Multimodal Imaging Marker For Efficient Sample Enrichment In Ad Clinical Trials Alzheimers & Dementia. 10. DOI: 10.1016/J.Jalz.2014.07.058  0.234
2003 Bradley K, Chappell R, Yuan Z, Odau H, Bruskewitz R, Jarrard D, Ritter M. Erectile dysfunction and prostate brachytherapy doses to the penile bulb and neurovascular bundles International Journal of Radiation Oncology*Biology*Physics. 57: S399-S400. DOI: 10.1016/S0360-3016(03)01330-0  0.233
2008 LaRowe TL, Mares JA, Snodderly DM, Klein ML, Wooten BR, Chappell R. Macular pigment density and age-related maculopathy in the Carotenoids in Age-Related Eye Disease Study. An ancillary study of the women's health initiative. Ophthalmology. 115: 876-883.e1. PMID 17868874 DOI: 10.1016/J.Ophtha.2007.06.015  0.232
2014 Jeraj R, Bradshaw T, Forrest L, Chappell R. Molecular Imaging Biomarkers of Response to Radiation Therapy in Canines With Spontaneously-Occurring Nasal Tumors International Journal of Radiation Oncology*Biology*Physics. 90: S195. DOI: 10.1016/J.Ijrobp.2014.05.735  0.231
1997 Chappell R, Newton MA, Larget B. 62 A new randomization method for allocating subjects Controlled Clinical Trials. 18: S79-S80. DOI: 10.1016/S0197-2456(97)91047-3  0.23
2010 Cruickshanks KJ, Nondahl DM, Tweed TS, Wiley TL, Klein BE, Klein R, Chappell R, Dalton DS, Nash SD. Education, occupation, noise exposure history and the 10-yr cumulative incidence of hearing impairment in older adults. Hearing Research. 264: 3-9. PMID 19853647 DOI: 10.1016/J.Heares.2009.10.008  0.229
2004 Gruber M, Chappell R, Millen A, LaRowe T, Moeller SM, Iannaccone A, Kritchevsky SB, Mares J. Correlates of Serum Lutein + Zeaxanthin: Findings from the Third National Health and Nutrition Examination Survey Journal of Nutrition. 134: 2387-2394. PMID 15333733 DOI: 10.1093/Jn/134.9.2387  0.228
2001 Fowler J, Chappell R, Ritter M. Confirmation of a low ratio of 1.5 Gy for prostate tumours European Journal of Cancer. 37. DOI: 10.1016/S0959-8049(01)81288-0  0.223
2013 Nash SD, Cruickshanks KJ, Klein R, Klein BE, Nieto FJ, Chappell R, Schubert CR, Tsai MY. Long-term variability of inflammatory markers and associated factors in a population-based cohort. Journal of the American Geriatrics Society. 61: 1269-76. PMID 23889670 DOI: 10.1111/Jgs.12382  0.22
2008 Chappell R. Textbook of Clinical Trials by Machin, D., Day, S., and Green, S Biometrics. 64: 658-658. DOI: 10.1111/J.1541-0420.2008.01026_9.X  0.22
2009 Binkley N, Harke J, Krueger D, Engelke J, Vallarta-Ast N, Gemar D, Checovich M, Chappell R, Suttie J. Vitamin K treatment reduces undercarboxylated osteocalcin but does not alter bone turnover, density, or geometry in healthy postmenopausal North American women. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 24: 983-91. PMID 19113922 DOI: 10.1359/Jbmr.081254  0.22
2009 Al-Niaimi AN, Egan K, Hartenbach EM, Connor JP, Seo S, Chappell R, Kushner DM. Minimally Invasive Radical Cervical Cancer Surgery: The Evolution of Innovation Journal of Minimally Invasive Gynecology. 16. DOI: 10.1016/J.Jmig.2009.08.023  0.22
2003 Mehta M, Tome W, Scrimger R, Welsh J, Chappell R, Fowler J, Mackie T. E-53. Helical tomotherapy: An innovative technological radiation therapeutic approach for lung cancer Lung Cancer. 41: S67-S68. DOI: 10.1016/S0169-5002(03)90460-0  0.219
2011 Johnson CJ, Herbst A, Duque-Velasquez C, Vanderloo JP, Bochsler P, Chappell R, McKenzie D. Prion protein polymorphisms affect chronic wasting disease progression. Plos One. 6: e17450. PMID 21445256 DOI: 10.1371/Journal.Pone.0017450  0.219
2017 Turski CA, Kessler-Jones A, Chow C, Hermann B, Hsu D, Jones J, Seeger SK, Chappell R, Boly M, Ikonomidou C. Extended Multiple-Field High-Definition transcranial direct current stimulation (HD-tDCS) is well tolerated and safe in healthy adults. Restorative Neurology and Neuroscience. 35: 631-642. PMID 29172010 DOI: 10.3233/Rnn-170757  0.216
1994 Chappell R. Presenting the coefficients of the linear quadratic formula for clinical use. International Journal of Radiation Oncology, Biology, Physics. 29: 191-3. PMID 8175430 DOI: 10.1016/0360-3016(94)90244-5  0.216
1994 Chappell R. 87P Practical issues in applying the restricted mean life Controlled Clinical Trials. 15: 125. DOI: 10.1016/0197-2456(94)90215-1  0.215
2016 Clark LR, Racine AM, Koscik RL, Okonkwo OC, Engelman CD, Carlsson CM, Asthana S, Bendlin BB, Chappell R, Nicholas CR, Rowley HA, Oh JM, Hermann BP, Sager MA, Christian BT, et al. Beta-amyloid and cognitive decline in late middle age: Findings from the Wisconsin Registry for Alzheimer's Prevention study. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 26806386 DOI: 10.1016/J.Jalz.2015.12.009  0.215
2014 Austin BP, Johnson S, Oh J, Bendlin BB, Gleason CE, Okonkwo O, Jacobson LE, Blazel H, Chappell R, Dowling NM, Rowley H, Sager MA, Asthana S, Carlsson CM. IC-P-102: THE RELATIONSHIP BETWEEN CEREBRAL PERFUSION, AGE, AND APOE4 IN MIDDLE-AGED ADULTS AT RISK FOR ALZHEIMER'S DISEASE Alzheimer's & Dementia. 10: P57-P58. DOI: 10.1016/J.Jalz.2014.05.108  0.214
2014 Nash SD, Cruickshanks KJ, Zhan W, Tsai MY, Klein R, Chappell R, Nieto FJ, Klein BE, Schubert CR, Dalton DS, Tweed TS. Long-term assessment of systemic inflammation and the cumulative incidence of age-related hearing impairment in the epidemiology of hearing loss study. The Journals of Gerontology. Series a, Biological Sciences and Medical Sciences. 69: 207-14. PMID 23739996 DOI: 10.1093/Gerona/Glt075  0.213
1995 Orzack SH, Chappell R. Sample-size determination for parent-offspring regression of a composite trait Biometrics. 51: 822-830. DOI: 10.2307/2532984  0.213
2012 Obasi CN, Cruickshanks KJ, Nondahl DM, Klein BE, Klein R, Nieto FJ, Shankar A, Fischer ME, Tsai MY, Chappell R. Association of Biomarkers for Inflammation, Endothelial Dysfunction and Oxidative Stress with Cognitive Impairment. The Epidemiology of Hearing Loss Study (EHLS). Oxidants and Antioxidants in Medical Science. 1: 169-173. PMID 23814681 DOI: 10.5455/Oams.031212.Br.004  0.213
1998 Chappell R, Miranpuri SS, Mehta MP. Dimension in defining tumor response. Journal of Clinical Oncology. 16: 1234-1234. PMID 9508213 DOI: 10.1200/Jco.1998.16.3.1234  0.212
1996 Noyes WR, Rodriguez R, Knechtle SJ, Pirsch JD, Sollinger HW, D'Alessandro AM, Chappell R, Belzer FO, Kinsella TJ. Radiation therapy for renal transplant rejection refractory to pulse steroids and OKT3. International Journal of Radiation Oncology, Biology, Physics. 34: 1055-9. PMID 8600088 DOI: 10.1016/0360-3016(95)02159-0  0.21
2014 Wichmann MA, Johnson SC, Zetterberg H, Blennow K, Gleason CE, Austin BP, Jacobson LE, Blazel HM, Bendlin BB, Okonkwo OC, Dowling NM, Chappell R, Asthana S, Carlsson CM. P2-118: CEREBROSPINAL FLUID MICROGLIAL MARKERS IN ALZHEIMER'S DISEASE, MCI, AND ASYMPTOMATIC ADULTS Alzheimer's & Dementia. 10: P514-P514. DOI: 10.1016/J.Jalz.2014.05.793  0.209
2011 Millen AE, Voland R, Sondel SA, Parekh N, Horst RL, Wallace RB, Hageman GS, Chappell R, Blodi BA, Klein ML, Gehrs KM, Sarto GE, Mares JA. Vitamin D status and early age-related macular degeneration in postmenopausal women Archives of Ophthalmology. 129: 481-489. PMID 21482873 DOI: 10.1001/Archophthalmol.2011.48  0.208
1977 Acosta D, Chappell R. Cardiotoxicity of diazepam in cultured heart cells. Toxicology. 8: 311-317. PMID 595023 DOI: 10.1016/0300-483X(77)90078-6  0.208
2014 Wichmann MA, Cruickshanks KJ, Carlsson CM, Chappell R, Fischer ME, Klein BE, Klein R, Tsai MY, Schubert CR. Long-term systemic inflammation and cognitive impairment in a population-based cohort. Journal of the American Geriatrics Society. 62: 1683-91. PMID 25123210 DOI: 10.1111/Jgs.12994  0.208
2014 Carlsson CM, Johnson S, Zetterberg H, Gleason CE, Bendlin BB, Okonkwo O, Austin BP, Dowling M, Chappell R, Wichmann M, Jacobson LE, Blazel H, Blennow K, Sager MA, Asthana S. Csf Biomarker Profiles In Middle-Aged Adults With Parental History Of Ad: The Wisconsin Adrc Cohorts Alzheimers & Dementia. 10. DOI: 10.1016/J.Jalz.2014.05.781  0.207
2003 Cruickshanks KJ, Tweed TS, Wiley TL, Klein BE, Klein R, Chappell R, Nondahl DM, Dalton DS. The 5-year incidence and progression of hearing loss: the epidemiology of hearing loss study. Archives of Otolaryngology--Head & Neck Surgery. 129: 1041-6. PMID 14568784 DOI: 10.1001/Archotol.129.10.1041  0.203
2002 Fowler JF, Chappell RJ, Ritter MA. The prospects for new treatments for prostate cancer. International Journal of Radiation Oncology, Biology, Physics. 52: 3-5. PMID 11777616 DOI: 10.1016/S0360-3016(01)02665-7  0.203
2002 Chappell R, Fowler JF, Ritter MA. In response to Drs. Dale and Jones International Journal of Radiation Oncology Biology Physics. 52: 1428. DOI: 10.1016/S0360-3016(01)02815-2  0.196
2004 Chappell R, Fowler J, Ritter M. New data on the value of alpha/beta--evidence mounts that it is low. International Journal of Radiation Oncology, Biology, Physics. 60: 1002-3. PMID 15465219 DOI: 10.1016/J.Ijrobp.2004.06.204  0.195
2002 Fowler J, Ritter M, Chappell R. In response to Dr. Denham International Journal of Radiation Oncology Biology Physics. 53: 1395. DOI: 10.1016/S0360-3016(02)02873-0  0.194
2002 Chappell R, Fowler JF. How to efficiently model Tpot and why we should care International Journal of Radiation Oncology Biology Physics. 54: 54. DOI: 10.1016/S0360-3016(02)03150-4  0.188
1997 Wang Q, Chappell R, Eisner A, Klein B, Jensen S, Moss S, Klein R. Pattern of age-related maculopathy in the macular area. The Beaver Dam Eye Study American Journal of Ophthalmology. 123: 282. DOI: 10.1016/S0002-9394(14)71068-2  0.188
1993 Love R, Barden H, Masess R, Chappell R. Effect of tamoxifen on lumbar spine bone mineral density in postmenopausal women after five years European Journal of Cancer. 29. DOI: 10.1016/0959-8049(93)91024-F  0.187
2014 Smith CB, Booth CJ, Wadzinski TJ, Legname G, Chappell R, Johnson CJ, Pedersen JA. Humic substances interfere with detection of pathogenic prion protein Soil Biology and Biochemistry. 68: 309-316. DOI: 10.1016/J.Soilbio.2013.10.005  0.187
1996 Chappell R. Re: Caplan et al. IJROBP 29:1183–1186; 1994, and Bentzen et al. IJROBP 32:1531–1534; 1995 International Journal of Radiation Oncology Biology Physics. 36: 988-989. PMID 8960538 DOI: 10.1016/S0360-3016(97)89873-2  0.185
2018 Chappell R. Comment on Vickers et al. Clinical Trials (London, England). 1740774518806868. PMID 30317868 DOI: 10.1177/1740774518806868  0.182
2004 Yuan Z, Chappell R. Isotonic designs for phase I cancer clinical trials with multiple risk groups Clinical Trials (London, England). 1: 499-508. PMID 16279290  0.155
1999 Miranpuri SS, Schulz CA, Chappell RJ, Kesava PP, Nguyen PH, Olsen M, McNutt TR, Mehta MP. Journal of Radiosurgery. 2: 153-161. DOI: 10.1023/A:1022970730375  0.114
2003 Fowler JF, Ritter MA, Chappell RJ, Brenner DJ. What hypofractionated protocols should be tested for prostate cancer? International Journal of Radiation Oncology, Biology, Physics. 56: 1093-104. PMID 12829147 DOI: 10.1016/S0360-3016(03)00132-9  0.106
2023 Du L, Hermann BP, Jonaitis EM, Cody KA, Rivera-Rivera L, Rowley H, Field A, Eisenmenger L, Christian BT, Betthauser TJ, Larget B, Chappell R, Janelidze S, Hansson O, Johnson SC, et al. Harnessing cognitive trajectory clusterings to examine subclinical decline risk factors. Brain Communications. 5: fcad333. PMID 38107504 DOI: 10.1093/braincomms/fcad333  0.096
2012 Chappell R. Competing risk analyses: how are they different and why should you care? Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 2127-9. PMID 22427347 DOI: 10.1158/1078-0432.Ccr-12-0455  0.093
2003 Liu G, Wilding G, Staab MJ, Horvath D, Miller K, Dresen A, Alberti D, Arzoomanian R, Chappell R, Bailey HH. Phase II study of 1alpha-hydroxyvitamin D(2) in the treatment of advanced androgen-independent prostate cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 9: 4077-83. PMID 14519629  0.092
2008 Engle DB, Bradley KA, Chappell RJ, Conner JP, Hartenbach EM, Kushner DM. The effect of laparoscopic guidance on gynecologic interstitial brachytherapy. Journal of Minimally Invasive Gynecology. 15: 541-6. PMID 18657479 DOI: 10.1016/J.Jmig.2008.06.001  0.089
2012 Olsen RL, Chappell RW, Loftis JC. Water quality sample collection, data treatment and results presentation for principal components analysis--literature review and Illinois River Watershed case study. Water Research. 46: 3110-22. PMID 22487543 DOI: 10.1016/J.Watres.2012.03.028  0.087
2023 Du L, Langhough R, Hermann BP, Jonaitis E, Betthauser TJ, Cody KA, Mueller K, Zuelsdorff M, Chin N, Ennis GE, Bendlin BB, Gleason CE, Christian BT, Plante DT, Chappell R, et al. Associations between self-reported sleep patterns and health, cognition and amyloid measures: results from the Wisconsin Registry for Alzheimer's Prevention. Brain Communications. 5: fcad039. PMID 36910417 DOI: 10.1093/braincomms/fcad039  0.071
2003 Fowler JF, Ritter MA, Fenwick JD, Chappell RJ. How low is the alpha/beta ratio for prostate cancer? In regard to Wang et al., IJROBP 2003;55:194-203. International Journal of Radiation Oncology, Biology, Physics. 57: 593-5; author reply . PMID 12957275 DOI: 10.1016/S0360-3016(03)00364-X  0.065
2008 Wiley TL, Chappell R, Carmichael L, Nondahl DM, Cruickshanks KJ. Changes in hearing thresholds over 10 years in older adults. Journal of the American Academy of Audiology. 19: 281-92; quiz 371. PMID 18795468 DOI: 10.3766/jaaa.19.4.2  0.064
2007 Johnson CJ, Pedersen JA, Chappell RJ, McKenzie D, Aiken JM. Oral transmissibility of prion disease is enhanced by binding to soil particles. Plos Pathogens. 3: e93. PMID 17616973 DOI: 10.1371/Journal.Ppat.0030093  0.055
2020 Chandereng T, Chappell R. How to do RAR if you really must. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 33111140 DOI: 10.1093/cid/ciaa1375  0.01
Hide low-probability matches.